Top of this page
Skip navigation, go straight to the content
Schwarz Pharma press releases
- SCHWARZ PHARMA Submits Marketing Application for it's Epilepsy compound Lacosamide 24-May-2007
- FDA Approves SCHWARZ PHARMA's Neupro for the Treatment of early-stage Parkinson's Disease in USA 10-May-2007
- Jürgen Baumann leaves SCHWARZ PHARMA 02-May-2007
- First Quarter Report 2007 25-April-2007
- SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology 16-April-2007
- Rotigotine Study to Investigate 24-hour-Action and Sleep Benefits in Parkinson's Patients 12-April-2004
- Domination and Profit Transfer Agreement 22-March-2007
- Full Year Report 2006: Sound Business Trend 26-February-2007
- Positive Results with Lacosamide in Diabetic Neuropatic Pain in Phase III trial 15-February-2007
- Neupro Now Approved in Europe for All Stages of Parkinson's Disease 16-January-2007
- Principle Decision on Group Integration of SCHWARZ PHARMA by Domination and Profit Transfer Agreement 11-January-2007
- Positive Results with Rotigotine in Restless Legs Syndrome in Second Phase III trial 11-January-2007
